1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market – By Technology

1.3.2        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market – By Application

1.3.3        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market – By End-User

1.3.4        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market – By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Circulating Tumor Cell (CTC) Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South & Central America PEST Analysis

4.3         Experts Opinion

5.           Circulating Tumor Cell (CTC) Diagnostics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Rising Demand for Minimally Invasive Diagnostic Procedures

5.2         Market Restraints

5.2.1        Dearth of Skilled Professionals Performing Diagnostic Procedures

5.3         Market Opportunities

5.3.1        Untapped Potential of Emerging Economies

5.4         Future Trends

5.4.1        Technological Advancements in Isolation of Circulating Tumor Cell

5.5         Impact Analysis

6.           Circulating Tumor Cell (CTC) Diagnostics Market– South & Central America Analysis

6.1         South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis

7.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Technology

7.1         Overview

7.2         South & Central America Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2020 & 2028 (%)

7.3         CTC detection and Enrichment Method

7.3.1        Overview

7.3.2        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.4         CTC Direct Detection Method

7.4.1        Overview

7.4.2        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.5         CTC Analysis

7.5.1        Overview

7.5.2        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Application

8.1         Overview

8.2         South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Share, By Application - 2020 & 2028 (%)

8.3         Clinical/Liquid Biopsy

8.3.1        Overview

8.3.2        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        Risk Assessment

8.3.3.1          Overview

8.3.3.2          Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Screening and Monitoring

8.3.4.1          Overview

8.3.4.2          Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Research

8.4.1        Overview

8.4.2        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.1          Cancer Stem Cell & Tumorigenesis Research

8.4.2.1.1          Overview

8.4.2.1.2          Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.2          Drug/Therapy Development

8.4.2.2.1          Overview

8.4.2.2.2          Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – End user

9.1         Overview

9.2         South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Research and Academic Institutes

9.4.1        Overview

9.4.2        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Centers

9.5.1        Overview

9.5.2        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market – Geographic Analysis

10.1      South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market

10.1.1     Overview

10.1.2     South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3     South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.4     South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.4.1       South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.1.4.2       South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.1.5     South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

10.1.6     South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.6.1       Brazil

10.1.6.1.1       Overview

10.1.6.1.2       Brazil: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3       Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.4       Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.4.1     Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.4.2     Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.5       Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

10.1.6.2       Argentina

10.1.6.2.1       Overview

10.1.6.2.2       Argentina: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3       Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.4       Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.4.1     Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.4.2     Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.5       Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

10.1.6.3       Rest of South and Central America

10.1.6.3.1       Overview

10.1.6.3.2       Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3       Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.4       Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.4.1     Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.4.2     Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.5       Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

11.        Impact of COVID-19 Pandemic on South & Central America Circulating Tumor Cell (CTC) Diagnostics Market

11.1      South & Central America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      THERMO FISHER SCIENTIFIC INC.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      STEMCELL Technologies Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      QIAGEN

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      FLUXION BIOSCIENCES

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2.             South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 3.             South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 4.             South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 5.             South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 6.             Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 8.             Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 9.             Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 10.          Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 11.          Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 13.          Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 14.          Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 15.          Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 20.          Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 21.          Organic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 22.          Inorganic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 23.          Glossary of Terms, Circulating Tumor Cell (CTC) Diagnostics Market

LIST OF FIGURES

Figure 1.           Circulating Tumor Cell (CTC) Diagnostics Market Segmentation

Figure 2.           South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Overview

Figure 3.           CTC detection and Enrichment Method Held Largest Share of Technology Segment in Circulating Tumor Cell (CTC) Diagnostics Market

Figure 4.           Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           South & Central America Circulating Tumor Cell (CTC) Diagnostics Market, Industry Landscape

Figure 6.           South & Central America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           South & Central America Circulating Tumor Cell (CTC) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.           South & Central America Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2020 & 2028 (%)

Figure 10.        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 11.        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Share, by Application - 2020 & 2028 (%)

Figure 14.        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

Figure 21.        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 25.        South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 27.        Brazil: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Argentina: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Impact of COVID-19 Pandemic in South & Central America Country Markets

Figure 31.        Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)